Prof Philipp Dahm: key facts
- Kind of voice
- Academic
- Role
- urologist at the University of Minnesota and senior author of the Cochrane review
- Quoted on
- Cancer
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
- First quoted
- 27 Aug 2026
“With new data now available, we can now say with moderate certainty that PSA screening reduces prostate cancer deaths in men with a sufficient life expectancy. This suggests that for the right patient – someone who is well-informed, has a good life expectancy, and understands the full implications of screening – there is now a reasonable evidence base to support a conversation about PSA screening.”
What Prof Philipp Dahm has said
“Prostate cancer screening does reduce prostate cancer mortality, although the caveat is that it takes a very extended period of time to realise that benefit. This finding is a milestone and I think it will make a difference for a lot of policymakers.”
urologist at the University of Minnesota and senior author of the Cochrane review · Cancer · 27 Aug 2026 · Prostate cancer screening can save lives but ‘absolute benefit is small’, study says ↗
Where Prof Philipp Dahm has been quoted
- Screening modestly reduces prostate cancer deathscochrane.org · 30 Sept 2026
- Prostate cancer screening can save lives but ‘absolute benefit is small’, study saystheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.